Eric Lefebvre is Chief Medical Officer at PLIANT THERAPEUTICS, INC. (PLRX). They have made 7 open-market trades across 1 company since 2020, most recently 2025-01-23.
CIK 0001614741
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PLRX | 240,224 | $204K |
Shares reported on the most recent Form 4, priced at the 2025-01-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PLRX | SELL · 10b5-1 | 2025-01-17 | 2025-01-22 | $11.20 | $414K | +4.1% | -71.3% | -86.0% |
| PLRX | SELL · 10b5-1 | 2024-07-10 | 2024-07-12 | $11.56 | $285K | -2.5% | -8.9% | -10.8% |
| PLRX | SELL · 10b5-1 | 2024-01-17 | 2024-01-19 | $17.23 | $355K | +7.4% | -6.8% | -26.9% |
| PLRX | SELL · 10b5-1 | 2023-07-17 | 2023-07-19 | $18.01 | $804K | +0.2% | -5.8% | -17.0% |
| PLRX | SELL · 10b5-1 | 2023-03-30 | 2023-04-03 | $26.52 | $596K | +0.2% | -9.7% | -31.9% |
| PLRX | SELL | 2023-01-23 | 2023-01-25 | $34.48 | $2.3M | -6.8% | -11.3% | -13.4% |
| PLRX | SELL | 2022-12-20 | 2022-12-21 | $19.10 | $416K | -1.3% | +18.3% | +44.6% |
| PLRX | SELL | 2022-10-25 | 2022-10-27 | $25.05 | $125K | -11.6% | -19.2% | +43.8% |
| PLRX | SELL | 2022-07-11 | 2022-07-13 | $20.00 | $60K | -5.8% | +17.2% | +26.7% |
| PLRX | SELL | 2021-06-18 | 2021-06-22 | $28.99 | $471K | -2.0% | -10.0% | -37.4% |
| PLRX | SELL | 2021-03-18 | 2021-03-19 | $39.40 | $940K | +1.4% | -26.7% | -21.3% |
| PLRX | SELL | 2020-12-18 | 2020-12-21 | $26.54 | $664K | -4.9% | -1.3% | +48.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.